|
Augustine Lawlor has been a Managing Director of HealthCare Ventures since 2000. He was previously chief operating officer of LeukoSite, Inc., a HealthCare Ventures III, IV, and V company. Before joining LeukoSite, Mr. Lawlor was chief financial officer and vice president of corporate development for Alpha-Beta Technology. He held similar positions at BioSurface Technology and Armstrong Pharmaceuticals. Mr. Lawlor has also served as a management consultant with KPMG Peat Marwick.Mr. Lawlor is currently a member of the board of directors of Catalyst Biosciences, Dynogen Pharmaceuticals, GlobeImmune, Human Genome Sciences, Medior, Replidyne, Synovex, U. S. Genomics, VaxInnate and the Slater Center in Providence, Rhode Island.Mr. Lawlor received his Master's degree in public and private management from Yale University. | 